NYSEAMERICAN:YCBD cbdMD (YCBD) Stock Price, News & Analysis → $1,500 to $9,400 in one month? (A.I. Trade List) (From Prosper Trading Academy) (Ad) Free YCBD Stock Alerts $0.66 -0.01 (-1.49%) (As of 05/24/2024 ET) Add Compare Share Share Today's Range$0.66▼$0.7250-Day Range N/A52-Week Range$0.56▼$2.19Volume121,482 shsAverage Volume291,080 shsMarket Capitalization$2.57 millionP/E RatioN/ADividend YieldN/APrice Target$3.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Get cbdMD alerts: Email Address cbdMD MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside352.5% Upside$3.00 Price TargetShort InterestHealthy7.87% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.49 out of 5 stars 3.5 Analyst's Opinion Consensus RatingcbdMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoveragecbdMD has received no research coverage in the past 90 days.Read more about cbdMD's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted7.87% of the float of cbdMD has been sold short.Short Interest Ratio / Days to CovercbdMD has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in cbdMD has recently decreased by 18.64%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldcbdMD does not currently pay a dividend.Dividend GrowthcbdMD does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for YCBD. Previous Next 0.8 News and Social Media Coverage News SentimentcbdMD has a news sentiment score of -0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 1 news article for cbdMD this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, cbdMD insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.95% of the stock of cbdMD is held by insiders.Percentage Held by InstitutionsOnly 7.18% of the stock of cbdMD is held by institutions.Read more about cbdMD's insider trading history. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of cbdMD is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of cbdMD is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatiocbdMD has a P/B Ratio of 0.83. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyObama’s Forever Term [exposed]America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here About cbdMD Stock (NYSEAMERICAN:YCBD)cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.Read More YCBD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart YCBD Stock News HeadlinesMay 18, 2024 | markets.businessinsider.comAnalyst Maintains ‘Buy’ Rating for cbdMD Amidst Challenges, Citing Brand Strength and Strategic InitiativesMay 16, 2024 | finance.yahoo.comcbdMD Inc (YCBD) Q2 2024 Earnings Call Transcript Highlights: Navigating Challenges with ...May 15, 2024 | msn.comcbdMD's Financial Results: Cost-Cutting Measures For Positive Cash Flow Amid Increasing LossesMay 15, 2024 | markets.businessinsider.comHere's what to expect from cbdMD's earningsApril 24, 2024 | forbes.comBest Lift Chairs For Seniors: A 2024 GuideMarch 23, 2024 | finance.yahoo.comcbdMD, Inc. (YCBD) Stock Historical Prices & Data - Yahoo FinanceFebruary 13, 2024 | finance.yahoo.comcbdMD Reduces Year over Year Net Loss from Operations by $3.0 MillionFebruary 8, 2024 | finance.yahoo.comcbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 ResultsFebruary 8, 2024 | finance.yahoo.comcbdMD Welcomes Vice President of Wholesale Sales, Joe Baghadjian- Paving the Way for Future GrowthFebruary 3, 2024 | msn.comcbdMD Secures $1.25M Through Convertible Note AgreementJanuary 31, 2024 | finance.yahoo.comcbdMD Unveils THCV+CBG Energy Softgels, Ushering in a New Era of Wellness SolutionsJanuary 18, 2024 | finance.yahoo.comcbdMD Launches into Sprouts Farmers Market, Bringing Premium CBD Gummies to 175 Stores NationwideJanuary 15, 2024 | benzinga.comcbdMD Stock (AMEX:YCBD), Guidance and ForecastDecember 30, 2023 | markets.businessinsider.comOptimistic Outlook: Buy Rating Affirmed for cbdMD Amid Growth Initiatives and Strategic ExpansionDecember 27, 2023 | msn.comYCBD Stock Earnings: cbdMD Reported Results for Q4 2023December 26, 2023 | benzinga.comCBD Giant's Challenging Year: Q4 Net Sales Slide By 27% But Net Loss Narrows 67% YoYDecember 22, 2023 | msn.comLaidlaw cuts Cingulate to hold, cites dwindling resourcesDecember 20, 2023 | finance.yahoo.comcbdMD, Inc. to Host Conference Call to Discuss September 30, 2023 Fourth Quarter and Fiscal Year 2023 ResultsDecember 14, 2023 | finance.yahoo.comcbdMD Wins Awards in Two Categories at Prestigious Best in Biz AwardsNovember 15, 2023 | seekingalpha.comYCBD.PR.A cbdMD, Inc. 8% SER A CUM PFDOctober 25, 2023 | finance.yahoo.comcbdMD Announces Cancellation of Special MeetingOctober 6, 2023 | nasdaq.comMaxim Group Initiates Coverage of cbdMD (YCBD) with Buy RecommendationOctober 5, 2023 | benzinga.comCosta Rica's FIFA-Recognized Soccer Team Turns To CBD For Injury Prevention & HealingOctober 5, 2023 | finance.yahoo.comcbdMD Announces Historic Partnership with FIFA-Affiliated Costa Rican Soccer TeamSeptember 22, 2023 | finance.yahoo.comcbdMD Announces Adjournment of Special MeetingSee More Headlines Receive YCBD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for cbdMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today5/26/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorBusiness Services Industry Toilet preparations Sub-IndustryN/A Current SymbolNYSEAMERICAN:YCBD CUSIPN/A CIKN/A Webwww.cbdmd.com Phone(704) 445-3060FaxN/AEmployees52Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.00 Low Stock Price Target$3.00 Potential Upside/Downside+352.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($12.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-22,940,000.00 Net Margins-102.25% Pretax Margin-102.25% Return on Equity-193.04% Return on Assets-109.90% Debt Debt-to-Equity Ratio0.88 Current Ratio1.07 Quick Ratio0.61 Sales & Book Value Annual Sales$24.16 million Price / Sales0.11 Cash FlowN/A Price / Cash FlowN/A Book Value$0.80 per share Price / Book0.83Miscellaneous Outstanding Shares3,870,000Free Float3,832,000Market Cap$2.57 million OptionableNot Optionable Beta1.98 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. T. Ronan Kennedy (Age 44)Interim CEO, CFO & Principal Executive Officer Comp: $275kDr. Sibyl Swift Ph.D. (Age 43)CSO, VP of Regulatory Affairs & Director Mr. Bradley Whitford (Age 43)Chief Accounting Officer, Treasurer & Secretary Zeb BookerChief Technology OfficerMr. John WestonDirector of Investor RelationsMr. Lance Blundell (Age 53)General Counsel Robert PettwayDirector of Public RelationsMr. Francisco Mangual (Age 45)Senior VP of Sales Ms. Shannon CharlesChief Marketing OfficerMr. David Johnson (Age 54)Senior VP of Business Development More ExecutivesKey CompetitorsVocodiaNYSEAMERICAN:VHAIFOXO TechnologiesNYSE:FOXOStaffing 360 SolutionsNASDAQ:STAFLeafbuyer TechnologiesOTCMKTS:LBUYNetcapitalNASDAQ:NCPLView All Competitors YCBD Stock Analysis - Frequently Asked Questions Should I buy or sell cbdMD stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for cbdMD in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" YCBD shares. View YCBD analyst ratings or view top-rated stocks. What is cbdMD's stock price target for 2024? 1 Wall Street analysts have issued 12-month price objectives for cbdMD's stock. Their YCBD share price targets range from $3.00 to $3.00. On average, they anticipate the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 352.5% from the stock's current price. View analysts price targets for YCBD or view top-rated stocks among Wall Street analysts. Are investors shorting cbdMD? cbdMD saw a decline in short interest in April. As of April 30th, there was short interest totaling 184,200 shares, a decline of 18.6% from the April 15th total of 226,400 shares. Based on an average trading volume of 320,300 shares, the days-to-cover ratio is presently 0.6 days. Approximately 7.9% of the shares of the company are sold short. View cbdMD's Short Interest. How were cbdMD's earnings last quarter? cbdMD, Inc. (NYSEAMERICAN:YCBD) released its quarterly earnings data on Wednesday, May, 15th. The company reported ($1.35) EPS for the quarter. The business had revenue of $4.82 million for the quarter. cbdMD had a negative trailing twelve-month return on equity of 193.04% and a negative net margin of 102.25%. What ETF holds cbdMD's stock? AXS Cannabis ETF holds 37,247 shares of YCBD stock, representing 0.35% of its portfolio. When did cbdMD's stock split? cbdMD shares reverse split before market open on Tuesday, April 25th 2023. The 1-45 reverse split was announced on Tuesday, April 25th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 25th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. What other stocks do shareholders of cbdMD own? Based on aggregate information from My MarketBeat watchlists, some companies that other cbdMD investors own include KushCo (KSHB), ADMA Biologics (ADMA), Novan (NOVN), Bionano Genomics (BNGO), CNBX Pharmaceuticals (CNBX), Enerplus (ERF), Matinas BioPharma (MTNB), Organigram (OGI) and Pennsylvania Real Estate Investment Trust (PEI). How do I buy shares of cbdMD? Shares of YCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:YCBD) was last updated on 5/26/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaWARNING about the death of the U.S. dollar…Colonial Metals$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsBiden replacement revealed?Paradigm PressNew Options need New Trading StrategiesNetpicksWrite this ticker symbol down…StocksToTradeThe only AI company to buyPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding cbdMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.